| Typicality: | 0.545 |
| Saliency: | 0.406 |
| for patient use | 5 | purpose |
| before considering whether to approve them | 5 | temporal |
| in three phases | 4 | temporal |
| drug → be tested for → efficacy | 29 |
| drug → be tested for → effectiveness | 16 |
| drug → be tested → effective | 15 |
| drug → test → their efficacy | 3 |
| negative | neutral | positive |
| 0.185 | 0.623 | 0.192 |
| Raw frequency | 63 |
| Normalized frequency | 0.406 |
| Modifier score | 0.875 |
| Perplexity | 114.135 |